Emerging pharmacologic treatment options for fragile X syndrome

Fragile X syndrome (FXS) is the most common single gene cause of intellectual disability and autism spectrum disorder. Caused by a silenced fragile X mental retardation 1 gene and the subsequent deficiency in fragile X mental retardation protein, patients with FXS experience a range of physical, beh...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaefer, Tori L, Davenport, Matthew H, Erickson, Craig A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396424/
https://www.ncbi.nlm.nih.gov/pubmed/25897255
http://dx.doi.org/10.2147/TACG.S35673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396424/
https://www.ncbi.nlm.nih.gov/pubmed/25897255
http://dx.doi.org/10.2147/TACG.S35673

Ejemplares similares